mifepristone has been researched along with Argentaffinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Bruin, C; de Herder, WW; Feelders, RA; Hofland, LJ; Lamberts, SW; Nieman, LK; Sprij-Mooij, DM; van Essen, M; van Koetsveld, PM; Waaijers, AM | 1 |
Broadus, AE; Deftos, LJ; Gazdar, AF; Ikeda, K; Lu, C; Mangin, M | 1 |
2 other study(ies) available for mifepristone and Argentaffinoma
Article | Year |
---|---|
Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Carcinoid Tumor; Cushing Syndrome; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Lung Neoplasms; Male; Middle Aged; Mifepristone; Receptors, Somatostatin | 2012 |
Glucocorticoid regulation of parathyroid hormone-related peptide gene transcription in a human neuroendocrine cell line.
Topics: Calcitonin; Carcinoid Tumor; Gene Expression Regulation; Glucocorticoids; Humans; Mifepristone; Multigene Family; Neoplasm Proteins; Neurosecretory Systems; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; RNA, Messenger; Transcription, Genetic; Triamcinolone; Tumor Cells, Cultured | 1989 |